K

Kotra Industries Bhd
KLSE:KOTRA

Watchlist Manager
Kotra Industries Bhd
KLSE:KOTRA
Watchlist
Price: 4.42 MYR -1.56%
Market Cap: 655.5m MYR
Have any thoughts about
Kotra Industries Bhd?
Write Note

Kotra Industries Bhd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kotra Industries Bhd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
K
Kotra Industries Bhd
KLSE:KOTRA
Interest Income Expense
-myr26k
CAGR 3-Years
68%
CAGR 5-Years
59%
CAGR 10-Years
44%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Interest Income Expense
-myr794k
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
-14%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Interest Income Expense
myr13.1m
CAGR 3-Years
43%
CAGR 5-Years
12%
CAGR 10-Years
42%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Interest Income Expense
-myr1.5m
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Interest Income Expense
-myr890k
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
-16%
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Interest Income Expense
-myr20.2m
CAGR 3-Years
-50%
CAGR 5-Years
-20%
CAGR 10-Years
-59%
No Stocks Found

Kotra Industries Bhd
Glance View

Market Cap
655.5m MYR
Industry
Pharmaceuticals

Kotra Industries Bhd.is an investment holding company, which engages in the manufacturing and trading of pharmaceutical and healthcare products. The company is headquartered in Malacca, Melaka and currently employs 660 full-time employees. The company went IPO on 2000-10-30. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd, is engaged in pharmaceutical and healthcare products manufacturing and trading business. Its segments include Malaysia, Asia and Africa. Its products include Appeton Multivitamin Pastilles, which is a healthy chewable pastille (non-sugar coated) for children; Axcel Glimepiride Medication, which is used to treat diabetes mellitus type 2; Axcel Bromhexine (Children) Syrup, which is a mucolytic medicine used in the treatment of respiratory chest congestion; Arite Beclometasone 50mcg (Metered Dose Inhaler Product), which is used in long-term management of asthma; Vaxcel Granisetron Injection, which is an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy, and Axcel Atenolol, which is used to treat high blood pressure and heart-associated chest pain.

KOTRA Intrinsic Value
4.62 MYR
Undervaluation 4%
Intrinsic Value
Price
K

See Also

What is Kotra Industries Bhd's Interest Income Expense?
Interest Income Expense
-26k MYR

Based on the financial report for Sep 30, 2024, Kotra Industries Bhd's Interest Income Expense amounts to -26k MYR.

What is Kotra Industries Bhd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
44%

Over the last year, the Interest Income Expense growth was 84%. The average annual Interest Income Expense growth rates for Kotra Industries Bhd have been 68% over the past three years , 59% over the past five years , and 44% over the past ten years .

Back to Top